ArticleDrugs in R&D2026

Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms.

Hua Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.